Preferred first-tier test for developmental delay, multiple anomalies, and autism-spectrum disorders. Testing is performed on peripheral blood.
Genomic Microarray (Oligo-SNP Array)
New York DOH Approval Status
Collect: Green (Sodium Heparin). Peripheral blood required. Also acceptable: Lavender (K2EDTA).
New York State Clients: Green (Sodium Heparin) AND Lavender (K2EDTA).
Transport 5 mL whole blood. (Min: 1 mL)
New York State Clients: Transport 4 mL whole blood in the original Green (Sodium Heparin) tube and 3 mL whole blood in the original Lavender (K2EDTA) tube. (Min: 2 mL Sodium Heparin and 2 mL EDTA).
Ambient: 48 hours; Refrigerated: 72 hours; Frozen: Unacceptable
New York State Clients: Ambient: 1 week; Refrigerated: 1 week; Frozen: Unacceptable
Refer to report.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online.
Laboratory Developed Test (LDT)
This test must be ordered using a Cytogenetic test request form 43097 or through your ARUP interface. Please submit the Genomic Microarray Patient Clinical Information Form with the electronic packing list (https://ltd.aruplab.com/Tests/Pdf/76).
|Component Test Code*||Component Chart Name||LOINC|
|2003415||Cytogenomic SNP Microarray||62375-1|
- Array CGH
- Array Comparative Genomic Hybridization
- Chromosomal Microarray
- Comparative Genomic Hybridization
- Congenital Array
- Constitutional Array
- Genomic Microarray
- Molecular Karyotype
- Oligo Array
- Oligonucleotide Array
- Single-nucleotide-polymorphism (SNP) array
- Targeted Array
- Whole Genome Array